Back to Search Start Over

P-133 - A randomized, multicenter, open-label controlled phase 2 trial of Foxy-5 as neoadjuvant therapy in patients with WNT5A negative colon cancer.

Authors :
Vermorken, J.
Cervantes, A.
Morsing, P.
Johansson, K.
Andersson, T.
Roest, N. Lindland
Gullbo, J.
Salazar, R.
Source :
Annals of Oncology. 2019 Supplement, Vol. 30, piv36-iv36. 1p.
Publication Year :
2019

Subjects

Subjects :
*NEOADJUVANT chemotherapy
*COLON cancer

Details

Language :
English
ISSN :
09237534
Volume :
30
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
152694236
Full Text :
https://doi.org/10.1093/annonc/mdz155.132
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details